Browse Articles
Discover research articles across all indexed journals
Split immunomodulatory impact of leptin on human myeloid cells: key role of IDO1 in counteracting the immunostimulatory effect of leptin
Abstract Obesity increases cancer incidence and aggressiveness but is paradoxically associated with improved response to immunotherapy. Here, we show that intratumoral levels of leptin (LEP), a factor contributing to the development of obesity, predict improved outcomes of breast and liver cancers. In contrast, these levels of LEP are associated with poor survival of patients with colon and esophageal cancers, where they are uniquely correlated with high IDO1 levels in tumor-associated myeloid cells. LEP-exposed human macrophages show elevated levels of multiple T cell–activating factors but also show NF-κB– and STAT3-dependent IDO1 induction, which synergize with IFN-γ in activating the kynurenine pathway, resulting in their T cell–suppressive function. IDO1 inhibition reprograms the LEP-exposed macrophages from metabolic suppression to enhanced T cell–stimulatory function. The double-edged impact of LEP on human myeloid cells helps explain obesity-associated immune dysfunction and the “obesity paradox,” suggesting that IDO1 inhibition may be selectively beneficial in patients who have obesity and cancer with high levels of LEP.
Ionic liquid-grafted PVDF membrane incorporated with g-C3N4-Fe3O4 for the removal of cationic dye and improved anti-bacterial activity
A mutation in <i>PTPN6</i> associated to emphysema alters B-lymphocyte biology in humans and mice
Abstract Our group discovered a mutation in a French-Canadian family causing a severe and early-onset form of emphysema. The heterozygote mutation located in the PTPN6 gene causes an alanine to threonine switch near the catalytic site of SHP-1, leading to a reduction of its enzymatic activity. In this study, we aimed to characterize the respiratory and immune abnormalities caused by this mutation in human carriers (PTPN6Ala455Thr) and mice carrying the equivalent mutation (Ptpn6Ala457Thr/+). Ptpn6Ala457Thr/+ mice spontaneously developed pulmonary tertiary lymphoid tissues (TLTs). They also exhibited a higher proportion of B-1 cells in both lung and spleen. Ptpn6Ala457Thr/+ mice had lower IgG1-specific antibodies to T-independent immunization, while their T-dependent response was normal. Human carriers showed reduced circulating naive B lymphocytes and increased memory B lymphocytes, a phenotype mainly observed in men, and had lower circulating levels of IgG1 and IgG4 as well as higher levels of IgG3. Spontaneous TLT formation in mice and alterations of B-cell biology in both humans and mice are caused by the mutation. This reinforces the link between emphysema, pulmonary TLT formation, and B cells; however, the exact mechanism involving B cells and pulmonary TLT in the development of emphysema remains elusive.
Rag1-based time-stamp tracing of T-cell developmental origins
Abstract The postnatal T‑cell pool comprises cells at diverse developmental stages, complicating efforts to resolve T‑cell differentiation, maturation, and long‑term adaptation. To address this challenge, we developed Rag1‑mediated time-stamp tracing, a genetic strategy that enables time‑resolved tracking of T‑cell developmental origins. We validate the specificity and temporal resolution of this approach across multiple analytical platforms, including flow cytometry, imaging, and single‑cell multiomics. Applying this strategy to thymic regulatory T (Treg) cell development, we show that time-stamp tracing resolves distinct phases of Treg cell induction, maturation, and long‑term adaptation within heterogeneous populations. This analysis identifies precursor populations for thymic Treg cell induction, uncovers a maturation program in nascent Treg cells marked by CD73 upregulation and progressive DNA hypomethylation at Treg cell–specific loci, and distinguishes long‑lived mature Treg cells characterized by activation and clonal expansion. Together, these findings establish Rag1‑based time-stamp tracing as a versatile and unbiased approach for resolving T‑cell developmental origins across immunological contexts.
IL-22 synergizes with IL-17 to promote mucosal inflammation and bone loss
Abstract Interleukin (IL)-22 mediates immune cell communication with nonhematopoietic cells and was shown to exert protective or destructive effects in different disease contexts. In the oral mucosal disease periodontitis, IL-22 has been associated with increased tissue destruction, although cause-and-effect evidence and the underlying mechanisms are lacking. Here, we showed that endogenous IL-22 was required for experimental periodontitis in mice, whereas local administration of exogenous IL-22 exacerbated periodontal inflammation and bone loss. Importantly, the ability of IL-22 to induce expression of inflammatory cytokines and tissue-degrading metalloproteinases as well as cause bone loss required intact IL-17 function, suggesting a potential cooperation between the two cytokines. As human fibroblasts prominently coexpress IL-22 and IL-17 receptors in the periodontal tissue and play a role in the pathogenesis of periodontitis, we examined them in vitro as potential targets of a destructive IL-22–IL-17 interplay. IL-22 synergized with IL-17 for enhanced nuclear factor κB–mediated inflammatory responses (IL-6, matrix metalloproteinase-1) in a STAT3-dependent manner. Analysis of cytosolic and nuclear extracts revealed that IL-22 enhanced nuclear factor κB p65 phosphorylation and translocation to the nucleus of IL-17–stimulated fibroblasts. In conclusion, our study provides causal evidence for IL-22 involvement in periodontitis and describes a hitherto unknown IL-22–IL-17 synergy in inflammatory bone loss.
FcγRIII blockade prevents anti-HLA–mediated platelet clearance in a humanized murine model of platelet transfusion refractoriness
Abstract Immune platelet transfusion refractoriness (iPTR) is a major complication in transfusion medicine. Although anti-HLA antibodies are recognized contributors, the mechanisms by which they drive platelet clearance remain incompletely defined. We examined sera from 18 patients with iPTR and found that anti-HLA antibodies induced uptake of human platelets expressing the cognate HLA-A2 target antigen and platelet particles derived from these platelets. These sera also mediated clearance of transgenic mouse platelets expressing human HLA-A2. Using THP-1–CD16A macrophages, uptake of both platelets and platelet particles was mediated predominantly through FcγRIIIa, with a partial contribution from FcγRI and little to no role for FcγRII. To test this pathway in vivo, we used a reductionist humanized murine model of iPTR in which HLA-A2 transgenic mouse platelets sensitized with human iPTR sera were transfused into FcγR-humanized mice. In this model, FcγRIII blockade with 17C02-albumin prevented platelet clearance under the conditions tested. These findings extend previous FcγR studies in antibody-mediated platelet clearance to the alloimmune setting of iPTR and support further investigation of FcγRIII-dependent pathways in antibody-mediated PTR.
Platelets are essential for survival of respiratory-restricted viral infection
Abstract Platelets are small, anucleate cells derived from megakaryocytes and are known for their essential role in hemostasis. Over the past decade, they have also emerged as important immune modulators, able to affect viral replication and leukocyte behavior. Most studies on platelets and viral infections have been focused on severe viremic infections. However, the role of platelets in respiratory-restricted infections remains unclear. We investigated the role of platelet-mediated immunity using murine respirovirus (SeV) as a model. First, in vitro experiments showed that platelets become activated in response to and internalize SeV. Next, a mouse model of platelet depletion was used to understand how platelets contribute to host defense against SeV in vivo. After intranasal (i.n.) infection, control mice with normal platelet counts had mild symptoms with few deaths. Despite no significant differences in viral load, platelet-depleted mice were highly susceptible to infection, had severe weight loss, and high mortality rates. Further analysis revealed that platelets modulate neutrophil responses in the lung. Platelet depletion increased neutrophil numbers but decreased neutrophil apoptosis, as evidenced via labeling of lungs with activated caspase 3. Additionally, we demonstrate platelets augment neutrophil apoptosis in the presence of SeV. Together, these data demonstrate that platelets are critical for host responses during respiratory viral infections through regulating neutrophil dynamics and not through controlling viral burden. This study reinforces platelets as a potential therapeutic target to combat severe pulmonary viral infection and to prevent its progression to life-threatening cases of bronchiolitis or respiratory failure.
Systemic and lung-resident memory elicited by OC43 coronavirus infection in mice
Abstract Endemic coronaviruses circulate seasonally and, while typically mild, can produce robust inflammation and severe pneumonia. Immunological memory to coronaviruses can be cross-reactive for multiple coronaviruses including OC43 and SARS-CoV-2. In this study, we used mouse models to investigate immune responses elicited by pulmonary infection with OC43. OC43 caused a mild, self-limiting infection. Early after infection, there was acute influx of myeloid cells and lymphocytes to the lung as well as a type I interferon–dependent production of IFN-γ. However, blocking interferons did not enhance viral infection. After recovery, lungs contained resident memory lymphocytes, and both the blood and lungs contained antibodies against OC43. When infection was supplemented with proinflammatory stimuli to model more severe disease, OC43-elicited immune changes were bolstered, including increased virus-specific plasma IgG and lung IgA, enhanced lung B-cell class-switching, and increased antigen-specific Th1 and Th17 cytokine production from lung CD4+ T cells. The antibodies and CD4+ T cells in mice recovered from OC43 infection, even with immunostimulatory agents, reacted only with OC43 proteins and peptides and not with those from other coronaviruses. Therefore, OC43 infection in wild-type mice does not induce the heterotypic immunity observed in humans. In conclusion, OC43 induces a self-limiting lung infection in mice accompanied by homotypic lung-resident and systemic memory, amplified by proinflammatory stimuli during infection.
Immunosuppressive effects of voclosporin in inflammatory bowel disease through targeted inhibition of SLP-76 and metabolic reprogramming
Abstract The adaptor protein SLP-76 plays a critical role in T-cell receptor signaling and immune activation, yet its relevance in inflammatory bowel disease (IBD) remains unclear. Although calcineurin inhibitors such as cyclosporine A (CsA) are used in severe ulcerative colitis, voclosporin (VCS), a novel calcineurin inhibitor approved for lupus nephritis, has not been systematically evaluated in IBD. We investigated whether SLP-76 is dysregulated in IBD and can be modulated by calcineurin inhibitors. Expression of SLP-76 was analyzed in intestinal biopsy specimens of patients with ulcerative colitis and Crohn’s disease using quantitative PCR (qPCR) and immunofluorescence. PBMCs from patients with IBD and healthy control participants were stimulated with anti-CD3/CD28 in the presence or absence of CsA or VCS. Downstream effects were analyzed by qPCR, flow cytometry, cytokine, and metabolic profiling. SLP-76 was significantly upregulated in inflamed intestinal tissue and correlated significantly with histological inflammation. No differences were observed in PBMCs between control participants and patients with IBD. Both calcineurin inhibitors reduced phosphorylation of SLP-76 and impaired downstream signaling in CD4+ and CD8+ T cells. However, only VCS significantly decreased total SLP-76 protein and suppressed expression of the early activation marker CD69 and Ras-MAPL signaling. Metabolomic profiling showed that VCS induced distinct metabolic changes compared with CsA. Our findings highlight SLP-76 as a potential immunoregulatory target in IBD and suggest that VCS exerts broader immunosuppressive effects than CsA, supporting its repurposing as a therapeutic strategy.
Single-cell analysis of ovarian immune cells reveals dynamic changes in NK and B-cell populations after ovarian stimulation
Abstract The mammalian ovary is the dynamic end-organ of the hypothalamic–pituitary–ovarian axis. In this coordinated system, ovarian cells undergo continuous cycles of apoptosis, proliferation, and differentiation. These changes parallel fluctuations in ovarian hormones such as estradiol; however, the ovarian immune microenvironment during high- and low-estradiol states remains incompletely defined. We induced a high-estradiol state in the mouse ovary by gonadotropin stimulation. Single-cell RNA sequencing and flow cytometry of ovarian leukocytes revealed abundant mature NK cells, B1 and B2 cells, CD8+ T cells, CD4+ T cells, mature CD4−CD8− T cells, T regulatory cells, and distinct myeloid subsets, including Trem2+ and Apoe+ macrophages. In vivo labeling of circulating cells indicated that the vast majority of ovarian leukocytes were tissue resident. Following gonadotropin treatment, the frequency of NK cells doubled, whereas that of B1 cells was reduced by half. Consistently, flow cytometry demonstrated an increase in mature CD11b+ NK cells after gonadotropin treatment. Cell–cell communication analysis further showed that gonadotropin treatment increased signaling by myeloid cells at the expense of NK cells. Collectively, these findings reveal a diverse, resident immune landscape in the ovary that responds robustly to hormonal changes, with implications for immune regulation in ovarian physiology and in pathological states.
Toll-like receptor responses are shaped by distinct MAPK activation profiles
Abstract Toll-like receptors (TLRs) are key sensors of infection and injury, and are critical inducers of inflammation. TLR-induced activation of the NF-κB and MAPK pathways promotes the secretion of mediators of inflammation such as cytokines and chemokines. Control of cytokine production is critically important, as unnecessary inflammatory responses can lead to tissue damage, while insufficient inflammatory responses can lead to susceptibility to infection. Previous studies showed that TLR4 uses distinct NF-κB and MAPK activation properties to discriminate between low and high concentrations of ligand, triggering cytokine production only at ligand concentrations that activate both pathways. The switch-like activation of MAPKs by TLR4 establishes an inflammatory threshold for ligand concentrations that facilitates threat discrimination. Using murine macrophages, we reveal that MAPK activation properties are TLR-specific, and that switch-like MAPK activation is not a general feature of all TLRs. Consequently, certain TLRs do not have an inflammatory threshold of ligand concentration and may not effectively filter signal from noise. The activation properties of the ERK pathway, rather than messenger RNA levels, dictate the patterns of TNFα cytokine secretion for all TLRs examined. We demonstrate that the TLR4 inflammatory threshold can be modulated by costimulation with granulocyte-macrophage colony-stimulating factor in an ERK-dependent manner. We show that deletion of BCL-3 changes the TLR4-induced ERK pathway activation properties from switch-like to gradual and lowers the activation threshold. We reveal that different TLRs have different capacities to discriminate threats based on ligand concentration, and that ERK pathway activation properties can be altered to change the cellular decision to initiate inflammation.
Distinct kinetic features of innate and adaptive responses in influenza A versus influenza B–infected mice
Abstract Influenza B infection is an important source of morbidity and mortality, especially in vulnerable populations such as children. Improved vaccines and antiviral therapeutics are hindered by gaps in knowledge about influenza B viruses (IBVs). We examined the immune responses in the lung, at the kinetic interface between the innate and adaptive response with a focus on the CD4 T-cell response to infection. Using a mouse model of infection with influenza A virus (IAV) A/California/04/2009 and influenza B virus (IBV) B/Brisbane/60/2008, striking differences in early cytokines and chemokines associated with induction of Th1-biased immune responses were identified. Quantifying these mediators on a temporal basis, IBV infection leads to earlier lung expression of the cytokines IFN-γ, IP-10, and MIP1-B in the lung relative to IAV. Given the critical role for IFN-γ in antiviral responses, the use of direct ex vivo cytokine staining and multiparameter flow cytometry revealed that, at day 6 after infection, when lung lysates contained the highest levels of IFN-γ, significant differences were found in the abundance of IFN-γ–producing Ly6C+ monocytes, CD4 T cells, and CD8 T cells in the IBV–infected lung, but not the IAV-infected lung. Data from a reporter mouse model of T-cell receptor engagement, epitope-specific cytokine enzyme-linked immunospot assays, quantitative lung cytokine abundance, and earlier viral clearance suggest a distinctive mechanism of IBV and IAV responses whereby the kinetics in recruitment of epitope-specific T cells to the IBV-infected lung is driven by early innate responses and leads to more rapid viral clearance.
T cell immunity to SARS-CoV-2 vaccination in inflammatory bowel disease patients treated with anti-cytokine biologics
Abstract Anti-TNF and anti-IL-12/IL-23 are commonly used therapies for immune-mediated inflammatory diseases (IMIDs), including inflammatory bowel disease (IBD). Although several studies have shown intact T cell responses following 2 to 3 doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in biologics treated IMID patients, our group previously reported increased waning of T cell responses at 3–4 mos following the second vaccine dose in IMID patients compared to healthy controls, raising the possibility that a suboptimal initial T cell response could impact long term immunity. Here, to reduce patient heterogeneity, we focused only on IBD patients and further investigated T cell responses in vaccinated, untreated and biologics treated IBD patients compared to healthy controls. Following 1 vaccine dose, we observed a decreased frequency of Spike-reactive Th1 polarized cells and an increased frequency of Th2 cells in the IBD patients in general, relative to healthy controls. Additionally, IBD patients exhibited increased waning of Spike-specific cytokine T cell responses after 2 doses of vaccine. We also observed IBD-treatment specific effects. Spike-specific IL-2 secretion from anti-TNF or anti–IL-12/IL-23–treated patients’ T cells was lower than from untreated patients following 1 dose of vaccine. However, single-cell RNA-sequencing of Spike-responsive T cells from anti-TNF and anti–IL-12/IL-23 treated IBD patients and healthy controls 2–4 wk after 2 or 3 vaccine doses revealed no major differences in T cell subsets, transcriptomes or TCR diversity. Thus, despite some evidence of impaired primary T cell responses, Spike-reactive T cells in patients treated with anti-TNF or anti–IL-12/IL-23 appear indistinguishable from healthy controls following a full vaccine course.
CD22 is upregulated and displays suppressive properties on CD4+ T cells upon a persistent virus infection
Abstract Chronic viral infections evade or suppress host immunity, posing risks to global human health. However, the underlying mechanisms of viral immune suppression are incompletely defined. Previously, we have demonstrated that sphingosine kinase 2 (SphK2) represses CD4+ T-cell immunity during lymphocytic choriomeningitis virus (LCMV) Clone 13 (Cl 13) infection. Here, our study indicates that CD22 is significantly upregulated on virus-specific T cells, which is largely dependent on SphK2, upon LCMV infection. The upregulation of CD22 on virus-specific T cells is sustained during persistent LCMV Cl 13 infection. While transient depletion of CD22 modestly enhances LCMV-specific T-cell responses, complete deletion of CD22 does not significantly affect T-cell immunity, suggesting the presence of a compensatory mechanism. Adoptively transferred CD22-deficient T-cell receptor transgenic LCMV-specific CD4+ T cells expand more effectively and exhibit improved functionality compared to CD22-sufficient T-cell counterparts. The results indicate that CD22 has a CD4+ T cell–intrinsic suppressive function during infection. Analysis of gene signature profiling further supports the regulatory role of CD22 in LCMV-specific CD4+ T cells. Collectively, the SphK2-CD22 axis during CD4+ T-cell immunity to infection could advance our understanding of virus-instigated immune suppression and viral persistence.
Unconventional functions of natural killer cells in homeostasis and disease
Abstract NK cells are classically defined by their rapid cytotoxicity against tumor cells and infected cells and by early inflammatory cytokine production. However, unconventional roles for NK cells as regulators of immunity and tissue homeostasis have recently been uncovered. Beyond their classical roles, NK cells can orchestrate leukocyte trafficking, curtail responses of other immune cells, remove protein aggregates, support pregnancy, and contribute to healthy tissue regeneration. We discuss the importance of these myriad functional activities of NK cells in infection, cancer, autoimmunity, atopic and allergic disease, pregnancy, tissue injury, and neurodegenerative diseases. The functional pleiotropy of NK cells provides new avenues of translational utility for these innate lymphocytes and represents an unexplored complexity in conventional clinical applications of NK cells against infection and cancer.
Fluorescence tracking CD8 T cells from tumor-draining lymph nodes to irradiated tumors and their activation in the tumor environment
Abstract Radiation is an effective site-specific cytotoxic therapy for cancer cells. In preclinical models, CD8 T cells are essential for optimum tumor control by radiation therapy, yet CD8 T cells are radiosensitive and depleted within the treatment field. Irradiated tumors can be refilled with T cells that were outside the field at the time of treatment. Using the Kaede photoconvertible mouse model we tracked CD8 T cells that originated in the tumor-draining lymph node and entered the tumor following radiation therapy. We show that radiation induces CD69 expression in newly infiltrating CD8 T cells within the tumor; however, this activation is not antigen-specific activation, but rather ois mediated by type I interferon released following radiation therapy. This effect is radiation dose dependent and requires cGAS expression in the cancer cells. Mathematical modeling demonstrates that radiation results in increased retention of surviving CD8 T cells in the tumor environment following treatment. By tracking the movement of tumor antigen-specific CD8 T cells from the tumor-draining lymph node to the tumor, we can observe that these cells rapidly express exhaustion markers in the tumor environment. These events occur in advance of radiation-mediated antigen-specific T cell expansion in the tumor-draining lymph node. These data formally demonstrate movement of CD8 T cells from the tumor-draining lymph node to the irradiated tumor and identify a mechanism of innate inflammation-mediated T cell activation that may impact T cell retention and accelerates refilling of the irradiated tumor.
Gut microbial composition modulates endogenous food-specific CD4+ T cells in food allergy
Abstract The growing food allergy epidemic is thought to be related to changing environmental factors, particularly changes in the gut microbiome. While prior work has demonstrated that food allergy can be modulated by gut microbes, little is known about how food allergen-specific CD4+ T cells are affected by gut microbial composition. Here, we report that food allergy severity differs between mice obtained from 2 different specific pathogen-free mouse vendors (Jackson Labs [Jax] and Taconic Biosciences [Tac]). Mice from Tac develop diarrhea and anaphylaxis after fewer allergen exposures than mice from Jax. Using food allergen peptide: MHCII tetramers, we also find that Tac mice have fewer allergen-specific regulatory T cells in the small intestine compared to mice from Jax with concomitant increase in allergen-specific Th2 cells. In addition, Tac mice have increased intestinal permeability. Increased food allergy severity, phenotype of allergen-specific T cells, and increased gut permeability were transferable to Jax animals via co-housing, which corresponded to a shift in Jax microbial communities towards those found in Tac mice. Our findings demonstrate that food allergen-specific Treg cells can be modulated by gut microbial community composition, which in turn is correlated to food allergy severity.
Lowering CD40L expression in murine lupus results in an increase in disease indicators in female but not male B6 mice
Abstract Our laboratory has previously described a mouse model (CD40LΔ5) that produces 60% of wild-type CD40L due to a targeted deletion in an RNA binding site within the CD40L message. The CD40LΔ5 mutation, which destabilizes CD40L mRNA during T-cell activation, causes disrupted germinal center (GC) formation, leading to reduced levels of memory B cells and switched antibodies. In this study, we used our model of limited CD40L expression to investigate its effect on systemic lupus erythematosus (SLE, or lupus) using 2 different mouse models of SLE. The first model used the hydrocarbon oil pristane to induce lupus-like symptoms over a 6-month period, and the second utilized a chronic graft-versus-host disease (bm12-cGVHD) that resembles lupus and allowed us to monitor the early events in disease development. Importantly, we found that in both systems, female mice expressing the CD40LΔ5 mutation showed a consistent increase in elevated antibody-secreting cells and autoantibody titers. In addition, pristane-induced lupus female CD40LΔ5 mice had higher levels of immunocomplex deposition in the kidney compared to all other cohorts. Increases in autoantibodies and GC cells in female CD40LΔ5 versus wild-type recipient mice were also evident in the bm12-cGVHD model. Additionally, CD4+ T cells from female CD40LΔ5 recipient mice were skewed toward a Th2 phenotype and expressed a distinct cytokine expression pattern upon activation of dendritic cells. Overall, our results support a nuanced role for optimal CD40L expression in lupus and suggest a sex-determined threshold of CD40L–CD40 signaling that is critical at the very early steps of disease progression.
CD8+ T-cell effector programming is epigenetically regulated by DUSP2 through BAF complex–driven chromatin remodeling
Abstract Effector gene expression in CD8+ T cells is tightly controlled at the epigenetic and transcriptional levels; however, crucial regulatory signals remain incompletely understood. In this study, we identify dual specificity phosphatase 2 (DUSP2) as a key epigenetic modulator of effector CD8+ T-cell state, by elucidating inhibition of BAF-mediated chromatin opening by DUSP2. Induced downregulation of DUSP2 in human CD8+ T cells enhances cytotoxicity and effector phenotypes by increasing chromatin accessibility through upregulation of BAF subunits, such as SMARCA4, and permitting binding of ETS1 to BAF subunit gene loci and those essential for effector programs. These findings uncover a previously unrecognized role of DUSP2 in the management of the chromatin landscape in effector CD8+ T cells and the epigenetic fine-tuning of their functionality, highlighting DUSP2 as a promising therapeutic target for T cell–based immunotherapy.
T-cell miR-155 regulates the response to tumor-specific mRNA vaccines in a murine model of acute myeloid leukemia
Abstract Acute myeloid leukemia (AML) is a malignant clonal expansion of myeloid progenitor cells that impedes normal hematopoiesis and culminates in bone marrow failure and death. The development of chemoresistant disease in response to first-line chemotherapies is common and indicates a need for new therapies. Tumor-specific mRNA vaccines have emerged as potent inducers of cellular immunity against solid tumors, yet their utility in targeting AML and the specific mechanisms that govern their broader activity remain poorly defined. Here, we demonstrate that microRNA-155 (miR-155) within T cells is vital for host anti-leukemia responses at baseline, and for mRNA vaccine–elicited cellular responses against AML. Loss of miR-155 in T cells in conditional knockout (TCKO) mice (miR-155 fl/fl CD4+Cre) results in deficient antitumor immunity against syngeneic ovalbumin-expressing C1498 murine AML (C1498-OVA). T cell–intrinsic miR-155 is required for terminal differentiation of short-lived effector KLRG1+ CD8+ T cells, thereby providing protective immunity induced by a tumor Ag–specific mRNA vaccine against C1498-OVA AML. Single-cell RNA sequencing reveals distinct miR-155–dependent transcriptomic regulation during the mRNA vaccine response. including changes indicative of a failure to appropriately respond to IFN-γ signaling in miR-155 TCKO CD8+ T cells. Notably, we identify a subset of genes modulated by miR-155 in CD8+ T cells specific to response to mRNA vaccination, indicating a novel and context-specific role for miR-155 in regulating the immune response to mRNA–lipid nanoparticle therapeutics. Together, these data indicate T cell–expressed miR-155 is a master regulator of intrinsic cellular immunity to AML and promotes tumor-specific mRNA vaccine responses.